Skip to content

Measurement of Urinary Catabolites of PACs as Biomarkers of Consumption of Cranberry Extracts

Measurement of Urinary Catabolites of the Proanthocyanidines (PACs) in Healthy Young Women as Biomarkers of Consumption of Cranberry Extracts.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02087735
Acronym
CUPACS
Enrollment
15
Registered
2014-03-14
Start date
2014-01-31
Completion date
2014-03-31
Last updated
2016-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infections

Keywords

Cranberry, Proanthocyanidins, Urinary catabolites

Brief summary

The purpose of this cross over pilot study is to investigate the urinary catabolites of Proanthocyanidines (PACs) as biomarkers of cranberry extracts in healthy young women.

Interventions

DIETARY_SUPPLEMENTCranberry extract

The aim of this pilot study is to evaluate the urinary catabolites of PACs as a biomarker of consumption of cranberry extracts within 9 hours of intercourse. Once a week, for 3 weeks, the women will receive a sequence of 3 different cranberry extracts (72 mg, 36 mg and 2mg (placebo)). The participant will have to collect its urine for a period of 9 hours in 3 different containers (one different container for 3 hours).

Sponsors

Laval University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy women. * 18 to 40 years.

Exclusion criteria

* No internet access. * No refrigerator access during the 9 hours of sample collection. * Women who had or expect to take antibiotic. * Women who had or expect to take cranberries, blueberries or bilberries in the form of berries, juice or extracts. * Women who had or expect to take dark chocolate. * Women who had personal history of acute or chronic renal failure.

Design outcomes

Primary

MeasureTime frame
Urinary catabolites of PACswithin 9 hours following the intake of cranberry extracts

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026